Compile Data Set for Download or QSAR
maximum 50k data
Found 436 of ic50 data for polymerid = 50006582,50006708,50006709,50006900,50006937,50006938,7093,7239
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
The University Of Texas M.D. Anderson Cancer Center

Curated by ChEMBL
LigandPNGBDBM50150818(CHEMBL3774575)
Affinity DataIC50:  7.60nMAssay Description:Inhibition of human N-terminal His-tagged KDM4A (1 to 359 residues) expressed in Escherichia coli using biotin-H3K9me3 as substrate preincubated for ...More data for this Ligand-Target Pair
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
The University Of Texas M.D. Anderson Cancer Center

Curated by ChEMBL
LigandPNGBDBM50150821(CHEMBL3775251)
Affinity DataIC50:  7.90nMAssay Description:Inhibition of human N-terminal His-tagged KDM4A (1 to 359 residues) expressed in Escherichia coli using biotin-H3K9me3 as substrate preincubated for ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
The University Of Texas M.D. Anderson Cancer Center

Curated by ChEMBL
LigandPNGBDBM50150820(CHEMBL3774933)
Affinity DataIC50:  8.30nMAssay Description:Inhibition of human N-terminal His-tagged KDM4A (1 to 359 residues) expressed in Escherichia coli using biotin-H3K9me3 as substrate preincubated for ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329912((s.e.)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(2-methox...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329913((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-{[2-(6-phenyl...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329914((rac)-[(1R,2R,3S,4R)-2,3-dihydroxy-4-({2-[3-(1-met...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329915((rac)-{(1R,2R,3S,4R)-4-[(2-{3-[2-chloro-1-(hydroxy...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
The University Of Texas M.D. Anderson Cancer Center

Curated by ChEMBL
LigandPNGBDBM449269(US10702504, Compound I-A6)
Affinity DataIC50: <10nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
The University Of Texas M.D. Anderson Cancer Center

Curated by ChEMBL
LigandPNGBDBM449285(US10702504, Compound I-A10)
Affinity DataIC50: <10nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
The University Of Texas M.D. Anderson Cancer Center

Curated by ChEMBL
LigandPNGBDBM449294(US10702504, Compound I-A11)
Affinity DataIC50: <10nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
The University Of Texas M.D. Anderson Cancer Center

Curated by ChEMBL
LigandPNGBDBM449296(US10702504, Compound I-A12)
Affinity DataIC50: <10nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
The University Of Texas M.D. Anderson Cancer Center

Curated by ChEMBL
LigandPNGBDBM449304(US10702504, Compound I-B2)
Affinity DataIC50: <10nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
The University Of Texas M.D. Anderson Cancer Center

Curated by ChEMBL
LigandPNGBDBM449307(US10702504, Compound I-B4)
Affinity DataIC50: <10nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
The University Of Texas M.D. Anderson Cancer Center

Curated by ChEMBL
LigandPNGBDBM50150808(CHEMBL3774507 | US10702504, Compound C)
Affinity DataIC50: <10nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
TargetTranscription intermediary factor 1-alpha(Homo sapiens (Human))
The University Of Texas M.D. Anderson Cancer Center

Curated by ChEMBL
LigandPNGBDBM50150812(CHEMBL3775853 | US10702504, Compound D)
Affinity DataIC50: <10nMAssay Description:The alpha assay was used to assess the binding of the compounds of the application to TRIM24 at various concentrations. All compounds were added at c...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329847((rac)-[(1R,2R,3S,4R)-4-{[2-(6-chloro-1H-indol-3-yl...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329848((rac)-((1R,2R,3S,4R)-4-((2-(Dibenzo[b,d]thiophen-4...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329849((rac)-((1R,2R,3S,4R)-4-(2-(5-chloro-2-(trifluorome...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329850((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(3-(1,1,1-...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329853((rac)-((1R,2R,3S,4R)-4-((2-(Benzo[b]thiophen-4-yl)...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329854((rac)-[(1R,2R,3S,4R)-4-{[2-(9H-carbazol-2-yl)pyraz...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM347108(US10202389, Compound I-063 | US10202389, Example 9...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329857((rac)-((1R,2R,3S,4R)-2,3-Dihydroxy-4-((2-(2-methox...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329858((rac)-((1R,2R,3S,4R)-2,3-Dihydroxy-4-((2-(2-methox...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329859((rac)-[(1R,2R,3S,4R)-2,3-dihydroxy-4-{[2-(2-phenyl...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329862((rac)-((1R,2R,3S,4R)-4-(2-(4-fluoro-2-methoxypheny...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329863((rac)-((1R,2R,3S,4R)-4-(2-(5-chlorobenzo[b]thiophe...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329864((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(2-methoyp...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329867((rac)-((1R,2R,3S,4R)-4-(2-(1H-indol-4-yl)pyrazolo[...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329868((rac)-((1R,2R,3S,4R)-4-(2-(3-(cyclopropylmethylthi...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329869((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(3-(piperi...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329870((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(3-morphol...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329873((rac)-((1R,2R,3S,4R)-4-(2-(5-fluorobenzo[b]thiophe...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329874((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(3-(2-meth...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329875((rac)-[(1R,2R,3S,4R)-4-{[2-(3-ethynylphenyl)pyrazo...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329876((rac)-((1R,2R,3S,4R)-4-(2-(3-(2-ethoxypropan-2-yl)...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329877((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(9-oxo-9H-...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329878((rac)-((1R,2R,3S,4R)-4-(2-(benzofuran-2-yl)pyrazol...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329879((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(3-(2-oxop...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329882((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(3-(2-prop...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329883((rac)-((1R,2R,3S,4R)-4-(2-(6-chlorobenzo[b]thiophe...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329884((rac)-((1R,2R,3S,4R)-4-(2-(5-chlorobenzofuran-3-yl...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329885((rac)-((1R,2R,3S,4R)-4-(2-(dibenzo[b,d]furan-3-yl)...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329886((rac)-((1R,2R,3S,4R)-4-(2-(5-ethylbenzo[b]thiophen...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329888((rac)-methyl rel-5-[7-({(1R,2S,3R,4R)-2,3-dihydrox...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329889((rac)-((1R,2R,3S,4R)-4-(2-(5-fluoronaphthalen-1-yl...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329794((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-{[2-(1-naphth...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM354140(US9796725, Compound I-099 | US9796725, Example 11)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329892((s.e.)-((1R,2R,3S,4R)-4-(2-(4-fluoronaphthalen-1-y...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSUMO-activating enzyme subunit 2(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329836((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(3-(triflu...)
Affinity DataIC50: <10nMAssay Description:he UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubiq...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 436 total ) | Next | Last >>
Jump to: